Stay updated on S65487 Combo with Azacitidine in AML Clinical Trial
Sign up to get notified when there's something new on the S65487 Combo with Azacitidine in AML Clinical Trial page.

Latest updates to the S65487 Combo with Azacitidine in AML Clinical Trial page
- Check4 days agoNo Change Detected
- Check11 days agoNo Change Detected
- Check19 days agoChange DetectedRevision: v3.5.0 appears, replacing the previous v3.4.3. This update is limited to page history metadata and does not affect the trial details.SummaryDifference0.2%

- Check26 days agoChange DetectedAdded revision v3.4.3 and removed revision v3.4.2 from the study history.SummaryDifference0.2%

- Check54 days agoChange DetectedA new version entry, Revision: v3.4.2, was added, while the funding notice and the earlier Revision: v3.4.1 entry were removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.7%

- Check61 days agoChange DetectedAdded a site-wide notice about government funding and updated the page revision to v3.4.1, while removing the previous revision v3.4.0. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.7%

- Check68 days agoChange DetectedThe page now includes a 'Show glossary' option and retains color-coded change highlights (green for additions, red for deletions). The revision text updated from v3.3.4 to v3.4.0 and the 'No FEAR Act Data' line was removed.SummaryDifference1.0%

- Check104 days agoChange DetectedA new Revision: v3.3.3 entry was added to the site history, and the HHS Vulnerability Disclosure and Revision: v3.3.2 entries were removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

Stay in the know with updates to S65487 Combo with Azacitidine in AML Clinical Trial
Enter your email address, and we'll notify you when there's something new on the S65487 Combo with Azacitidine in AML Clinical Trial page.